|
The National Agency for Research and Innovation (ANII) has awarded Xeptiva Therapeutics with a new grant “Tools for Innovation”. The Grant was applied by Xeptiva last october and was approved by the ANII to begin next March 2023.
The Project is entitled "Development of immunotherapies for the veterinary market” and seeks to improve the innovation capabilities of the startup. The Project presented and approved by the Agency consists of 4 verticals, hiring specialized human resources, both in the scientific and veterinary areas, internships for postgraduate students, conducting controlled clinical trials on dogs with osteoarthritis, and training human resources abroad, which will allow the company to acquire capabilities and access technologies not available in our country. |
The project constitutes a subsidy of approximately 70% of the total amount assigned to the project contributed by ANII and 30% contributed by Xeptiva, and will last 24 months. This governmental grant constitutes a fundamental support for Xeptiva since it will allow the company to improve its research and innovation capabilities by hiring new specialized human resources, perform clinical trials and access to new technologies aborad. About Xeptiva Xeptiva Therapeutics LLC is a clinical stage biotech company dedicated to the development of immunotherapies to threat conditions associated with chronic neuroinflammation in companion animals.
The company was created with the mission to improve companion animal’s health span (quality of life) and lifespan (years of life) by developing simple, affordable, disruptive, and highly effective immunotherapies. About ANII The National Agency for Research and Innovation (ANII) is a government entity that promotes research and the application of new knowledge to the productive and social reality of Uruguay. ANII makes funds available to the public for research projects, national and international postgraduate scholarships and incentive programs for innovative culture and entrepreneurship, both in the private and public sectors.
ANII developed the National System of Researchers, a program of economic incentives for national researchers categorized based on a strict evaluation system. He also created the Timbó Portal, which allows free access to all kinds of scientific publications from around the world for all Uruguayans. The ANII works as a mechanism for articulation and coordination between the actors involved in the development of knowledge, research and innovation.
The company was created with the mission to improve companion animal’s health span (quality of life) and lifespan (years of life) by developing simple, affordable, disruptive, and highly effective immunotherapies. About ANII The National Agency for Research and Innovation (ANII) is a government entity that promotes research and the application of new knowledge to the productive and social reality of Uruguay. ANII makes funds available to the public for research projects, national and international postgraduate scholarships and incentive programs for innovative culture and entrepreneurship, both in the private and public sectors.
ANII developed the National System of Researchers, a program of economic incentives for national researchers categorized based on a strict evaluation system. He also created the Timbó Portal, which allows free access to all kinds of scientific publications from around the world for all Uruguayans. The ANII works as a mechanism for articulation and coordination between the actors involved in the development of knowledge, research and innovation.